Impact Slides: MR CLEAN to SWIFT-PRIME With Patrick Lyden, MD

More 'happy talk' and still not acknowledging that ER stroke interventions successfully reverse stroke a miniscule number of times.
Medium f*cking whoopee.

http://www.medpagetoday.com/Cardiology/Strokes/52214?
What are the key points from the recent spate of positive trials for mechanical thrombectomy for certain large-vessel ischemic strokes? Patrick D. Lyden, MD, explores the significance of MR CLEAN, SWIFT-PRIME, and other randomized trials.
Lyden serves as chair of the department of neurology and director of the stroke program at Cedars-Sinai Medical Center in Los Angeles. He was an investigator on the key tissue plasminogen activator (tPA) trial in the mid-1990s and remains on the editorial boards of Stroke, the International Journal of Stroke, and the Journal of Stroke and Cerebrovascular Disease.

3:36 minutes of video explanation.